Collaboration brings AI-driven insights and science-backed supplementation together to support measurable healthspan gains.
The longevity sector has long promised to bridge the gap between data and daily life – but turning geroscience into actionable, evidence-based habits remains a formidable challenge. Now, a new collaboration between AI longevity platform Rejuve.AI and Longevity.Technology’s consumer brand FLT (Fueling Longevity Today) aims to make that connection tangible, integrating measurable data, personalized insights and rigorously curated supplementation into one ecosystem.
FLT is built on Longevity.Technology’s near decade-long expertise tracking and analyzing the science of aging. Designed to translate research into practical, consumer-ready interventions, FLT’s formulations are evidence-led and transparency-focused, each product supported by peer-reviewed data and manufactured in the US under Good Manufacturing Practice standards, ensuring consistency and traceability across batches. Rejuve.AI, meanwhile, specializes in using AI and large-scale data analytics to generate individualized longevity insights, leveraging N-of-1 experimentation and self-reported outcomes to map how interventions work across different populations.
Together, the two companies hope to bring scientific precision to the supplement space – an area often criticized for bold claims and limited data. The collaboration will allow users to integrate Rejuve.AI’s personalized tracking and biomarker analytics with FLT’s curated product range, building a feedback loop between intervention and measurement.
Dev Heaton, Head of FLT, said: “The future of longevity isn’t just about discovering new molecules – it’s about understanding how individuals respond to them. Partnering with Rejuve.AI gives us a way to connect our formulations with real-world data, helping people see how cellular, cognitive and physical performance can evolve over time. It’s a step toward personalization that’s rooted in science, not guesswork.”
Longevity.Technology: As the longevity field matures, the distinction between “research” and “routine” is beginning to blur – data is no longer the sole province of the lab but the scaffolding of everyday health decisions. Evidence-backed supplementation, paired with intelligent tracking, offers a practical bridge between discovery and self-care; yet it demands the same rigor, transparency and restraint that we apply to any scientific endeavor. The partnership between Rejuve.AI and FLT is a timely experiment in that balance – using AI not to amplify hype, but to make precision, feedback and accountability part of the longevity toolkit.
From data to decisions
FLT’s formulations target specific functional goals: FLT Cognition for mental clarity, FLT Muscle for strength and recovery, and FLT Longevity for cellular resilience and metabolic support. Each blend combines clinically tested compounds such as ErgoActive (ergothioneine), L-theanine, PeptiStrong, creatine, Niagen (nicotinamide riboside), spermidine and fisetin – ingredients studied for their effects on energy metabolism, neuroprotection and senescence clearance.
Each formulation is paired with accessible scientific references, allowing consumers to review the clinical evidence behind the ingredients – a level of transparency that reflects FLT’s commitment to data-led design.
AI as a feedback engine
Rejuve.AI brings the other half of the equation: an intelligent platform designed to analyze individual data, lifestyle inputs and biomarker results to generate adaptive health insights. Its community-driven model focuses on N-of-1 experimentation – the collection of personalized data over time to understand how interventions perform in real life.
By combining Rejuve.AI’s analytics with FLT’s clinically grounded formulations, the collaboration aims to enable users to observe measurable changes in performance and biological aging markers. This feedback loop could eventually help refine supplement strategies based on individual response, driving the move toward genuinely personalized longevity.
Toward measurable healthspan
Both organizations share a focus on closing the gap between the promise of longevity science and the practicality of implementing it. Rejuve.AI’s founder network and FLT’s scientific advisors envision a future in which AI models can identify which longevity compounds work best for specific profiles – integrating subjective wellbeing with objective biological data.
At its core, the partnership represents a shift in how longevity is practiced: less about one-size-fits-all supplementation, more about tailored interventions that evolve alongside each user’s data. It also reflects a growing trend toward transparency and validation within the supplement space, as companies recognize the importance of publishing evidence and tracking outcomes rather than relying on anecdote.
A new model for preventive longevity
As geroscience moves from the research bench into everyday health strategies, partnerships like this point to how the field might evolve – blending machine learning, measurable metrics and molecular interventions into one continuous system. It’s a pragmatic, data-led approach to preventive health – less promise, more proof.
To celebrate the collaboration, FLT is offering readers an exclusive 10% discount on all products for a limited time! Just add the discount code flt10 at checkout – CLICK HERE to shop.
